Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Amber Gibson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Bridged Bicyclo Compounds, Heterocyclic, Sulfonamides, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
This retrospective study at the University of Texas MD Anderson Cancer Center evaluated frontline venetoclax combination therapy in 11 pediatric/adolescent patients with acute myeloid leukemia (AML). Despite the small sample size and retrospective nature, the treatment demonstrated safety and potential efficacy, with most patients achieving early complete remission. Adverse events were consistent with other AML therapies, and no discontinuations due to toxicity occurred. While acknowledging study limitations, including selection bias and diverse concurrent therapies, this research underscores the promising role of venetoclax in pediatric AML. Further investigation is crucial to validate its long‐term efficacy in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Amber Gibson, David McCall, Miriam Garcia, Jiasen He, Michael Roth
Zitieren
APA
Gibson, A., Dickson, S., McCall, D., Garcia, M., Connors, J., He, J., Roth, M., Nunez, C., & Cuglievan, B. (2024). Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31286
Vancouver
Gibson A, Dickson S, McCall D, Garcia M, Connors J, He J, et al. Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31286
BibTeX
@article{Gibson2024,
author = {Gibson, Amber and Dickson, Samantha and McCall, David and Garcia, Miriam and Connors, Jeremy and He, Jiasen and Roth, Michael and Nunez, Cesar and Cuglievan, Branko},
title = {Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31286}
}
EUVIMED